- Home
- EPWK vs CSCI Comparison
EPWK vs CSCI Comparison
Compare EPWK & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPWK
- CSCI
- Stock Information
- Founded
- EPWK 2011
- CSCI 1990
- Country
- EPWK China
- CSCI Canada
- Employees
- EPWK N/A
- CSCI N/A
- Industry
- EPWK
- CSCI
- Sector
- EPWK
- CSCI
- Exchange
- EPWK Nasdaq
- CSCI NYSE
- Market Cap
- EPWK 11.0M
- CSCI 10.6M
- IPO Year
- EPWK 2025
- CSCI 1996
- Fundamental
- Price
- EPWK $0.52
- CSCI $3.53
- Analyst Decision
- EPWK
- CSCI
- Analyst Count
- EPWK 0
- CSCI 0
- Target Price
- EPWK N/A
- CSCI N/A
- AVG Volume (30 Days)
- EPWK 1.2M
- CSCI 2.4K
- Earning Date
- EPWK 05-27-2025
- CSCI 08-12-2025
- Dividend Yield
- EPWK N/A
- CSCI N/A
- EPS Growth
- EPWK N/A
- CSCI N/A
- EPS
- EPWK N/A
- CSCI N/A
- Revenue
- EPWK $20,164,008.00
- CSCI $9,030,000.00
- Revenue This Year
- EPWK N/A
- CSCI N/A
- Revenue Next Year
- EPWK N/A
- CSCI N/A
- P/E Ratio
- EPWK N/A
- CSCI N/A
- Revenue Growth
- EPWK 10.25
- CSCI 36.51
- 52 Week Low
- EPWK $0.41
- CSCI $1.96
- 52 Week High
- EPWK $26.00
- CSCI $7.43
- Technical
- Relative Strength Index (RSI)
- EPWK N/A
- CSCI N/A
- Support Level
- EPWK N/A
- CSCI N/A
- Resistance Level
- EPWK N/A
- CSCI N/A
- Average True Range (ATR)
- EPWK 0.00
- CSCI 0.00
- MACD
- EPWK 0.00
- CSCI 0.00
- Stochastic Oscillator
- EPWK 0.00
- CSCI 0.00
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.